Phase I Study of Ex Vivo Expanded/Activated Gamma Delta T-cell Infusion Following Haploidentical Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
Status: Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 20 Jan 2020
Price : $35 *
At a glance
- Drugs Allogeneic-gamma-delta-T-cell-therapy (Primary)
- Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Haematological malignancies; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 26 Nov 2019 According to an Incysus Therapeutics media release, this trial is expected to begin shortly.
- 23 Sep 2019 Planned initiation date changed from 15 Sep 2019 to 15 Oct 2019.
- 20 Jun 2019 Planned initiation date changed from 15 May 2019 to 15 Sep 2019.